GlassScriptPhysician profile
Lauri S Last
NPI 1962589648
$921.39
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Public Health & General Preventive Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $202.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $262.08 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $202.43 | 2019-2020 | |
| Amarin Pharma, INC. | $116.22 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $89.19 | 2019-2020 | |
| Lilly USA, LLC | $63.70 | 2019-2020 | |
| Novo Nordisk INC | $58.28 | 2019-2020 | |
| Glaxosmithkline, LLC. | $54.64 | 2019 | |
| Sanofi-Aventis U.S. LLC | $38.87 | 2019 | |
| Pfizer INC. | $21.58 | 2020 | |
| Sanofi Pasteur INC. | $14.40 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauri Last listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.